Novocure wins FDA nod for Optune Pax as pancreatic cancer treatment
February 12, 2026
Novocure (Nasdaq:NVCR) announced that the FDA granted approval for its Optune Pax treatment for advanced pancreatic cancer.
Novocure (Nasdaq:NVCR) announced that the FDA granted approval for its Optune Pax treatment for advanced pancreatic cancer.
BRECKSVILLE, Ohio, Feb. 12, 2026 /PRNewswire/ — Applied Medical Technology, Inc. (AMT) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Explant Express®, a breast implant removal device designed to support efficient, controlled explantation of ruptured silicone breast implants.
A multidisciplinary study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and published in Circulation Research provides a new perspective on why this arrhythmia can persist long-term, highlighting the key role of non-contractile cardiac cells.
A new MRI technique called Velocity Spectrum Imaging can map fluid movement in the human brain within a 3D pixel.
With a new MRI technique that shows both heart tissue and blood flow simultaneously, physicians can see where heart defects occur and precisely plan to repair them, according to new research.
An international research team has gained new insights into the dynamics of myelin swellings in the brain.
A new AI tool that accurately predicts the need for a feeding tube could transform patient care and improve quality of life for people living with Motor Neuron Disease (MND).
The IOTA ADNEX ultrasound tests picked up 9 out of 10 women with cancer.
For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer.
Researchers led by Min Zhang and Dabao Zhang of the University of California, Irvine’s Joe C. Wen School of Population & Public Health have created the most detailed maps to date showing how genes causally regulate one another across different types of brain cells affected by Alzheimer’s disease.